The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $954,325 in first-year total cost, median $232,758.
Most frequent study sections
- Special Emphasis Panel[ZRG1 IMST-L (10)]2
- Special Emphasis Panel[ZRG1 IMST-F (10)]1
- Special Emphasis Panel[ZRG1 IMST-K (14)]1
Most frequent institutions
- GLYCAN THERAPEUTICS CORPORATION1
- GLYCOSCIENTIFIC, LLC1
- NOVAB, INC.1
- PROTEIN METRICS, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Development of Isotopically Labeled Glycoproteins for use as Internal Standards2R42GM113666-02 | ORLANDO, RON | GLYCOSCIENTIFIC, LLC, GA | $352,644 | ZRG1 |
| 2017 | Comprehensive Glycoproteomic Tool Development for Cancer Biomarkers2R42GM112750-03A1 | BERN, MARSHALL WAYNE | PROTEIN METRICS, LLC, CA | $315,614 | ZRG1 |
| 2017 | Developing Heparan Sulfate Glycan Array1R41GM123792-01A1 | LIU, JIAN | GLYCAN THERAPEUTICS CORPORATION, NC | $149,901 | ZRG1 |
| 2017 | Monoclonal lamprey VLR antibodies specific for mucin-type O-linked glycan core 1 - 4 structures1R41GM126590-01 | CANNON, LOVICK EDWARD | NOVAB, INC., GA | $136,166 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.